does glp 1 target visceral fat GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Focus on Glucagon-like Peptide-1 Target:

In: Arnaud MJ, editor

10.1055/s-0038-1628584 Nervenheilkunde 151 SheuJ.-R.HsiehC.-Y.JayakumarT.LinG.-Y.LeeH.-N.HuangS.-W.et al (2019)

It directly engages peripheral receptors without first altering hypothalamic pulses

CJC-1295 Without DAC (Modified GRF 1-29) Modified GRF (1-29) commonly referred to in research as CJC-1295 without DAC is a synthetic analogue of endogenous GHRH, representing a further-modified form of Sermorelin (GRF 1-29) with four strategic amino acid substitutions incorporated to prevent enzymatic degradation and oxidation, while increasing binding affinity to the GHRH receptor

A doctor can provide a diagnosis and recommend the best treatments.